🔗 Visit the ClinicalTrials.gov page for NCT02536794
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. | Nat Rev Clin Oncol | 2016 | 1.18 |
| 2 | Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond. | Ther Adv Med Oncol | 2016 | 0.77 |
| 3 | Future perspectives in cancer immunotherapy. | Ann Transl Med | 2016 | 0.77 |